Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report

Published:October 11, 2022DOI:



      Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare neoplasm that occurs mostly in women younger than 40 years of age. The unknown histogenesis makes the diagnosis of SCCOHT difficult. SCCOHT was recently shown to be associated with SMARCA4 gene mutation. Serum calcium levels can be used as a marker of treatment response and relapse in SCCOHT.

      Case Report

      Here we report on a 16-year-old girl who presented with pelvic mass and hypercalcemia. SCCOHT was diagnosed histopathologically. However, loss of neither BRG1 nor INI1 expression was detected.

      Summary and Conclusion

      The diagnosis of SCCOHT should be among the differential diagnoses in adolescents presenting with pelvic mass and hypercalcemia. We would like to share our experience with this rare case, discuss recent management, and emphasize the importance of a multidisciplinary approach. Although it is known that almost all cases have a loss of BRG1 expression and a small group exhibit loss of INI1, our patient indicates that there could be exceptional cases with hitherto undescribed genetic abnormalities.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tischkowitz M
        • Huang S
        • Banerjee S
        • et al.
        Small-cell carcinoma of the ovary, hypercalcemic type–genetics, new treatment targets, and current management guidelines.
        Clin Cancer Res. 2020; 26: 3908-3917
        • Korivi BR
        • Javadi S
        • Faria S
        • et al.
        Small cell carcinoma of the ovary, hypercalcemic type: clinical and imaging review.
        Curr Probl Diagn Radiol. 2018; 47: 333-339
        • Lu B
        • Shi H:
        An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings.
        J Cancer. 2019; 10: 223
        • Witkowski L
        • Goudie C
        • Foulkes WD
        • McCluggage WG:
        Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis.
        Surg Pathol Clin. 2016; 9: 215-226
        • Brookfield KF
        • Cheung MC
        • Koniaris LG
        • et al.
        A population-based analysis of 1037 malignant ovarian tumors in the pediatric population.
        J Surg Res. 2009; 156: 45-49
        • Young RH
        • Oliva E
        • Scully RE:
        Small cell carcinoma of the ovary, hypercalcemic type: a clinicopathological analysis of 150 cases.
        Am J Surg Pathol. 1994; 18: 1102-1116
        • Aggarwal D
        • Gupta P
        • Chhabra P
        • et al.
        Small cell carcinoma of ovary, hypercalcemic type: cytologic, histopathologic, and immunohistochemical landscapes of a rare case.
        J Pediatr Adolesc Gynecol. 2021; 34: 98-102
        • Pautier P
        • Ribrag V
        • Duvillard P
        • et al.
        Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.
        Ann Oncol. 2007; 18: 1985-1989